NCT02550977View on ClinicalTrials.gov

Russia/Ukraine Suppression of Ovarian Activity Study

PHASE2CompletedINTERVENTIONAL

Enrollment

91

Participants

Timeline

Start Date

September 18, 2015

Primary Completion Date

July 15, 2016

Study Completion Date

August 15, 2016

Conditions

Contraception

Interventions

DRUG

Gestodene/EE Patch (BAY86-5016)

7 day patch containing 0.55 mg ethinyl estradiol and 2.1 gestodene in a 21 day regimen.

Trial Locations (8)

69068

Zaporizhzhya

115280

Moscow

197374

Saint Petersburg

199034

Saint Petersburg

214019

Smolensk

350063

Krasnodar

664003

Irkutsk

04050

Kiev

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY